COVIDMED - An early pandemic randomized clinical trial of losartan treatment for hospitalized COVID-19 patients.

Freilich, Daniel; Victory, Jennifer; Jenkins, Paul; Gadomski, Anne

Freilich, Daniel; Victory, Jennifer; Jenkins, Paul; Gadomski, Anne.

Afiliação

Freilich D; Bassett Medical Center, 1 Atwell Rd, Cooperstown, NY, 13326, USA.
Victory J; Bassett Research Institute, 1 Atwell Rd, Cooperstown, NY, 13326, USA.
Jenkins P; Bassett Research Institute, 1 Atwell Rd, Cooperstown, NY, 13326, USA.
Gadomski A; Bassett Research Institute, 1 Atwell Rd, Cooperstown, NY, 13326, USA.

Contemp Clin Trials Commun ; 29: 100968, 2022 Oct.

Article em En | MEDLINE | ID: mdl-35874909

Palavras-chave

Angiotensin II receptor Blocker (ARB); Angiotensin converting enzyme inhibitor (ACEi); COSS, COVID-19 Ordinal Severity Score; COVID-19; Losartan; Randomized clinical trial (RCT); SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article